COMMUNIQUÉS West-GlobeNewswire

Biocartis Group NV: Biocartis and A*STAR's ETPL initiate development of breast cancer assay to guide therapy selection
10/07/2017
PRESS RELEASE: 10 July 2017, 07:00 CEST Biocartis and A*STAR's ETPL initiate development of breast cancer assay to guide therapy selection Singapore / Mechelen (Belgium) , 10 July 2017 - Biocartis Group NV ('Biocartis' [...]
SelectMDx to be Distributed Across Middle East by IPS Genomix
10/07/2017
MDxHealth establishes commercial agreement with regional experts NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION HERSTAL, BELGIUM - July 10, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced that it has [...]
IPS GenomiX devient distributeur de SelectMDx au Moyen-Orient
10/07/2017
MDxHealth a établi un accord commercial avec des experts régionaux COMMUNIQUE DE PRESSE / INFORMATION REGLEMENTAIRE / INFORMATION PRIVILEGIEE HERSTAL, BELGIQUE - 10 juillet 2017 - MDxHealth SA (Euronext : MDXH.BR) a [...]
Guerbet annonce un plan de rationalisation de sa gamme de produits de contraste
10/07/2017
Villepinte, le 10 juillet 2017 (7h00) - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l'imagerie médicale, annonce aujourd'hui qu'il va cesser progressivement la [...]
Guerbet Announces Plans to Streamline Its Contrast Media Portfolio
10/07/2017
Villepinte (France), July 10, 2017 (7:00 AM CET) - Guerbet (FR0000032526 GBT), the global specialist in contrast products and solutions for medical imaging, announced today that it will phase out sales throughout the [...]
Guerbet Announces Plans to Streamline Its Contrast Media Portfolio
10/07/2017
Villepinte (France), July 10, 2017 (7:00 AM CET) - Guerbet (FR0000032526 GBT), the global specialist in contrast products and solutions for medical imaging, announced today that it will phase out sales throughout the [...]
Merus to Report First Quarter 2017 Financial & Mid-Year Operating Results on July 11, 2017
07/07/2017
Conference call and webcast scheduled on 4:30pm ET UTRECHT, The Netherlands, July 06, 2017 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody [...]
Merus communiquera les résultats financiers du premier trimestre 2017 et les résultats d'exploitation de mi exercice le 11 juillet 2017
07/07/2017
Conférence téléphonique et diffusion sur le Web prévues à 16 h 30 HNE UTRECHT, Pays-Bas, le 6 juillet 2017 (GLOBE NEWSWIRE) - Merus N.V. (Nasdaq:MRUS), une société d'immuno-oncologie de stade clinique qui développe des [...]
MPI: Oncology Venture and Eisai Forge Exclusive Global License Agreement for Clinical Stage Oncology Drug PARP Inhibitor E7449 - 2X-121
07/07/2017
2X Oncology to conduct Phase 2 Study of 2X-121 in metastatic breast cancer patients Hoersholm, Denmark, and Cambridge, MA, July 7, 2017 - Oncology Venture AB ("Oncology Venture") and 2X Oncology Inc. ("2X Oncology"), [...]
DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social
07/07/2017
Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]
DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company
07/07/2017
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]
Targovax ASA: Notification of trade by primary insiders
07/07/2017
Reference is made to the stock exchange announcement dated 3 July 2017 in which Targovax ASA (the "Company") announced the commencement of the subscription period of the rights issue by the Company of 2,000,000 new [...]
CrownBio démontre des progrès scientifiques dans les maladies métaboliques avec un modèle translationnel validé et amélioré pour la découverte de médicaments contre l'obésité et le diabète de type 2
07/07/2017
SANTA CLARA, Californie, le 7 juillet 2017 (GLOBE NEWSWIRE) - Crown Bioscience , une filiale en propriété exclusive de Crown Bioscience International (TWSE : symbole boursier 6554) et une société mondiale de services de [...]
Changes in Oriola's Group Management Team
07/07/2017
Oriola Corporation Stock Exchange Release 7 July 2017 at 11.00 Changes in Oriola's Group Management Team Page Content Anders Torell (b. 1967), M.Sc.Eng., has been appointed Vice President of Oriola's Consumer Business [...]
Curetis To Attend Key Investor and Scientific Conferences In The Third Quarter 2017
07/07/2017
Curetis To Attend Key Investor and Scientific Conferences In The Third Quarter 2017 Amsterdam, the Netherlands, and Holzgerlingen, Germany, July 7, 2017 -- Curetis N.V. (the " Company " and, together with Curetis GmbH [...]
Zealand Pharma A/S convenes an extraordinary general meeting 2017
07/07/2017
Zealand Pharma A/S indkalder til ekstraordinær generalforsamling 2017 Zealand Pharma A/S convenes an extraordinary general meeting 2017 Indkaldelse til ekstraordinær generalforsamling i Zealand Pharma A/S (CVR-nr. 20 04 [...]
argenx presents full data from ARGX-111 Phase Ib study in patients with advanced cancers over-expressing the MET protein at Best of ASCO Asia 2017 (Singapore)
07/07/2017
July 7, 2017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment [...]
Zealand Pharma files registration statement for proposed initial public offering of ADSs in the U.S.
06/07/2017
Company announcement - No. 25/2017 Zealand Pharma files registration statement for proposed initial public offering of ADSs in the U.S. Zealand has today filed a registration statement for the proposed initial public [...]
VALNEVA : Déclaration d'actions et de droits de vote - Juin 2017
06/07/2017
VALNEVA Déclaration d'actions et de droits de vote - JUIN 2017 Dénomination sociale : VALNEVA Adresse du siège social : World Trade Center Lyon, Tour Oxygène, 10-12 Boulevard Marius Vivier Merle, 69003 Lyon Marché [...]

Pages